drugset / Trial / NCT00356954

NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization

NCT00356954

Phase 4 Completed 250 enrolled Seoul National University Hospital
RandomizedParallel-groupDouble-blindPrevention

Summary

The contrast induced nephropathy (CIN) has been known to be associated with significant clinical and economic consequences. Many studies were performed to find the pathophysiology and preventive measures for CIN. But the results were somewhat frustrating. Recently, it has been reported that the N-acetylcysteine and ascorbic acid might have preventive effects for CIN by their antioxidant effects.There have been no study to compare these two antioxidant.

Timeline

Start
2005-02
Primary completion
Completion
2006-04

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcystein Unknown
Subject Vitamin C Other / unclassified

Indications